XML 20 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues [Abstract]      
Net revenues $ 422,969 $ 481,969 $ 453,911
Operating costs:      
Salaries and related costs 235,629 274,233 259,228
Rent, supplies, contract labor and other 84,336 90,379 88,426
Provision for credit losses 4,623 4,858 4,603
Closure costs - lease and other 2,072 25 (9)
Closure costs - derecognition of goodwill 1,859 0 0
Total operating costs 328,519 369,495 352,248
Gross profit 94,450 112,474 101,663
Corporate office costs 42,037 45,049 41,349
Operating income 52,413 67,425 60,314
Other income and expense:      
Relief funds 13,501 0 0
Gain on sale of partnership interest and clinics 1,091 5,514 0
Gain on derecognition of debt 0 0 1,846
Interest and other income, net 142 46 93
Interest expense - debt and other (1,634) (2,079) (2,042)
Total other income and expense 13,100 3,481 (103)
Income before taxes 65,513 70,906 60,211
Provision for income taxes 13,022 13,647 11,369
Net income 52,491 57,259 48,842
Less: net income attributable to non-controlling interests:      
Non-controlling interests - permanent equity (6,122) (6,561) (5,536)
Redeemable non-controlling interests - temporary equity (11,175) (10,659) (8,433)
Net income attributable to non-controlling interests (17,297) (17,220) (13,969)
Net income attributable to USPH shareholders $ 35,194 $ 40,039 $ 34,873
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 2.48 $ 2.45 $ 1.31
Shares used in computation - basic and diluted (in shares) 12,835 12,756 12,666
Dividends declared per common share (in dollars per share) $ 0.32 $ 1.14 $ 0.92
Net Patient Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 373,340 $ 433,345 $ 417,703
Other Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 49,629 $ 48,624 $ 36,208